Search

everythinglearnresearchcommunity

for

Search:↓

A new treatment using nanoparticles can effectively prevent and reduce hair loss caused by chemotherapy.

Palbociclib generally maintains or improves quality of life in advanced breast cancer patients.

Pimozide treatment resolved cysts and partially restored cheek fat in a man with Barraquer–Simons syndrome.

A man developed oral hairy leukoplakia while on baricitinib, a medication for alopecia and arthritis, and doctors should watch for such side effects.

Baricitinib may help people with long-term alopecia areata.

Patients with severe alopecia areata felt better and less anxious or depressed when treated with baricitinib compared to placebo.

Baricitinib helped a woman with severe hair loss regrow almost all her hair without side effects.

Ritlecitinib improves hair regrowth satisfaction in alopecia areata patients.

Oral tofacitinib significantly improves lichen planopilaris symptoms without adverse effects.

PPAR-γ helps control skin oil glands and inflammation, and its disruption can cause hair loss diseases.

Anlotinib combined with taxane/capecitabine is more effective than bevacizumab for treating HER-2 negative metastatic breast cancer.

Baricitinib is effective and cost-efficient for treating severe alopecia areata in adults.

Baricitinib effectively promotes hair regrowth in alopecia areata patients with mild side effects.

The Li-Pa/Ca and Do/Ca chemotherapy regimens for serous ovarian cancer showed better short-term and long-term results than the Pa/Ca regimen.

PRIDE syndrome helps identify skin side effects from EGFR inhibitors like erlotinib.

Baricitinib may effectively treat sudden hair whitening and regrowth in some cases.

Rapamycin may help treat Leigh syndrome by targeting protein kinase C.

A man developed temporary hair loss after taking a cancer drug, which might indicate a better treatment response.

Topical calcitriol appears safe and may reduce hair loss during chemotherapy.

Pantethine may boost the immune system's ability to fight sarcoma.

An elderly man with skin amyloidosis and abnormal blood proteins was monitored without finding widespread disease after 18 months.

Baricitinib effectively regrows hair in most people with severe alopecia, especially those with patchy hair loss, but hair may fall out again if treatment stops.

Baricitinib can help improve hair loss and skin color issues in people with Down syndrome.

Oclacitinib maleate successfully treated alopecia in Andean bears.

A new compound shows promise as a topical treatment for hair loss.

Nanocapsules can improve clobetasol delivery to hair follicles, reducing side effects.

Ritlecitinib improved hair regrowth and emotional well-being in some alopecia areata patients.

Baricitinib quickly improved severe alopecia areata, with almost total hair regrowth in three months.

Ritlecitinib is effective for long-term hair regrowth in alopecia areata, especially in females and early treatment.

Dabrafenib was effective and well tolerated in treating thyroid cancer with a specific mutation.